Cherry Hemangioma Treatment & Management
- Author: Clarence William Brown, Jr, MD, FAAD; Chief Editor: Dirk M Elston, MD more...
Medical intervention is not helpful and not indicated in the treatment of the benign vascular proliferations of cherry hemangiomas. Perform biopsy on lesions in which the diagnosis is doubtful. The biopsy procedure may be used as a therapeutic measure to remove traumatized or bleeding lesions.
Treatment for cherry hemangioma lesions is recommended only in situations of irritation or hemorrhage or in instances in which the lesions are deemed by the patient to be cosmetically undesirable.
Shave excision allows delicate removal of the lesion by blade and histologic confirmation of the diagnosis. Hemostasis following removal may be obtained by chemical means (aluminum chloride) or by performing electrocautery.
Curettage and electrodesiccation techniques permit reliable elimination of the lesion through tissue destruction. The risk of scarring usually is minimal when the technique is performed by a skilled operator.
Pulsed-dye laser ablation of lesions may be performed for cosmesis. The use of a pulsed dye laser with a green light source allows selective absorption of the laser energy by the hemoglobin contained within the red blood cells and subsequent obliteration of the vascular lumen.[6, 7, 8]
Cryotherapy is a less well-controlled means by which lesions are eliminated through irritation, coagulation, and subsequent destruction.
Sclerotherapy of individual lesions has been shown to have limited therapeutic benefit in treating cherry angiomas.
Dermatologist consultation may be indicated. For multiple cherry hemangiomas that have appeared over a short period, refer the patient for evaluation to exclude an internal malignancy. In several patients, cherry hemangiomas that have erupted over a very short period were associated with an internal malignancy.
The occurrence of cherry angiomas has never been demonstrated to have any relationship to diet.
The occurrence of cherry angiomas has never been shown to be related to the level of physical activity.
Köhn FM. [Penile cherry angiomas]. MMW Fortschr Med. 2014 Nov 6. 156 (19):65. [Medline].
Pembroke AC, Grice K, Levantine AV, Warin AP. Eruptive angiomata in malignant disease. Clin Exp Dermatol. 1978 Jun. 3(2):147-56. [Medline].
Wu YT, Chang JM. Segmental dyschromatosis with blue naevi and cherry angiomas: a new syndrome?. Clin Exp Dermatol. 2014 Oct. 39 (7):819-21. [Medline].
Ma HJ, Zhao G, Shi F, Wang YX. Eruptive cherry angiomas associated with vitiligo: provoked by topical nitrogen mustard?. J Dermatol. 2006 Dec. 33(12):877-9. [Medline].
Zhu LL, Zheng S, Wei H, Hong YX, Zhang L, Zhang L, et al. Multiple cutaneous malignancies and cherry hemangiomas in a vitiligo patient treated with topical nitrogen mustard. Dermatol Ther. 2014 Jan-Feb. 27 (1):52-4. [Medline].
Dawn G, Gupta G. Comparison of potassium titanyl phosphate vascular laser and hyfrecator in the treatment of vascular spiders and cherry angiomas. Clin Exp Dermatol. 2003 Nov. 28(6):581-3. [Medline].
Gupta G, Bilsland D. A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol. 2000 Aug. 143(2):356-9. [Medline].
Bernstein EF. The pulsed-dye laser for treatment of cutaneous conditions. G Ital Dermatol Venereol. 2009 Oct. 144(5):557-72. [Medline].
Jairath V, Dayal S, Jain VK, Jindal N, Gogna P, Sehrawat M, et al. Is sclerotherapy useful for cherry angiomas?. Dermatol Surg. 2014 Sep. 40 (9):1022-7. [Medline].
James WD, Berger TB, Elston D, eds. Dermal and subcutaneous tumors: cherry angiomas. Andrew's Diseases of the Skin: Clinical Dermatology. 11h ed. Philadelphia, Pa: WB Saunders; 2011. 574-619.